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DISCUSSION
DrMartin R. Back (Tampa, Fla). Duplex ultrasound surveil-
lance after infrainguinal vein bypass construction has been associ-
ated with meaningful extension of vein graft longevity by allowing
repair of stenotic lesions threatening patency. Graft revision meth-
ods have evolved over the last 10 years with increasing acceptance
of percutaneous transluminal balloon angioplasty as a durable
option. However, the optimal match of stenotic lesion type and
treatment method has not been fully determined.
Dr Hagino and his colleagues at San Antonio have dissected
their recent experience with secondary interventions for vein graft
stenoses using a rigorous statistical analysis to identify factors
prognosticating outcomes for endovascular and open techniques.
Their findings are not dissimilar with other series, including our
group’s experience reported in 1999. Early developing, defined as
occurring within 6 months of construction, and multiple lesions
shortened graft patency regardless of treatment method. Interven-
tions for anastomotic stenoses fared worse than repairs of graft
body lesions. Stenoses longer than 2 cm and mid-graft lesions
responded better to open repairs and probably accounted for a
general trend towards a shorter interval to restenosis seen after
endovascular interventions. Despite this latter trend, increased
graft occlusion was not observed after endovascular repairs owing
to the ability of serial scanning to effectively allow additional
re-interventions for restenoses.
I would like to thank the authors for providing me the
manuscript early and allowing me ample time to struggle through
the complex data set and its interpretation. I will limit my com-
ments regarding multiple problems with confusing patency defini-
tions and text clarity that will mandate extensive revision and better
explanation and illustration of their methods and results. I have
several queries.
First, for completeness, what was your graft surveillance pro-
tocol pre- and post-interventions? Was intraprocedural duplex
scanning used and/or how soon afterwards was imaging done as a
gauge of procedural (or technical) success? What was your proce-
dural end point for success after endovascular and open repairs, and
did this have any bearing on later outcomes?
Second, vein graft diameter has been acknowledged as a
prognostic factor for treatment durability after endovascular inter-
vention with smaller diameter veins (less than 3.5 mm) behaving
unfavorably. Have you recorded or could you extract graft diame-
ter information from duplex scans prior to intervention to include
this parameter in your statistical analysis?
Lastly, procedural-related complications were not detailed in
the manuscript. Would their greater occurrence after open repairs
influence risk/benefit considerations and affect selection of the
preferred treatment method for any specific lesion characteristic?
Dr Ryan T. Hagino (San Antonio, TX). Thank you, Dr
Back for your questions and comments. I have found the often-
quoted practice of defining endovascular clinical end points in
terms of target lesion recurrence or reintervention rates unhelpful
in clinical practice, and I really felt the more useful end point was
overall graft patency, in other words, freedom from occlusion. And
so we tried to present our data using cumulative assisted patency.
In other words, we tried to distinguish between the end points of
graft occlusion (primary assisted patency) vs the need for secondary
interventions inclusive of graft occlusions (primary patency).
Regarding our graft surveillance protocol, certainly the South
Florida group has championed this, and then we have adopted
your guidelines for both revision and surveillance. In terms of
intraprocedural duplex, for all open repairs—both reinterventions
and the primary index procedure—we perform intraoperative du-
plex ultrasound. I did not include revisions that were performed at
the time of surgery.
Following endovascular procedures, we have not been as
aggressive as your group in terms of doing intraprocedural duplex
imaging. It is something I would like to adopt, but the practicali-
ties of our practice locations make intraprocedural scanning for
endoluminal interventions a little bit more difficult than for open
procedures. Therefore, we end up declaring technical success in
relationship to residual stenosis rather than hemodynamic resolu-
tion of the offending lesion as would be seen with intraoperative
duplex imaging, and I acknowledge that this leads to an inequality
between the groups.
In terms of vein graft diameter, I do recognize that as a
limitation and going back and trying to comb the data looking for
graft specific diameter in the absence of a prospective protocol was
impossible, so we were not able to follow that end point.
Regarding the procedure-related complications, certainly,
open procedures have their fair share of wound complications.
There was a significant difference in complications rates between
the endovascular and the open groups, with the endovascular
groups sustaining more complications. These complications were
not insubstantial. I can recall at least two or three interventions
where we had distal embolization and had to go after them with
thrombectomy catheters and percutaneous extraction techniques,
so it is by no means benign.
JOURNAL OF VASCULAR SURGERY
December 20071172 Hagino et al
